PMID- 16035398 OWN - NLM STAT- MEDLINE DCOM- 20051107 LR - 20151119 IS - 1368-504X (Print) IS - 1368-504X (Linking) IP - 144 DP - 2004 Oct TI - Effect of nimesulide on the serum levels of hyaluronan and stromelysin-1 in patients with osteoarthritis: a pilot study. PG - 13-9 AB - This prospective preliminary single-blind study was conducted in patients suffering from osteoarthritis (OA) and requiring non-steroidal anti-inflammatory drugs (NSAIDs) to determine to what extent nimesulide (200 mg/day) and ibuprofen (1200 mg/day) could induce significant changes in the serum levels of matrix metalloproteinase-3 (MMP-3), tissue inhibitor-1 of MMPs (TIMP-1), hyaluronan (HA) and YKL-40 after a therapeutic time period of 28 days. The four biochemical parameters were assessed by using immunoassays. Nimesulide significantly reduced the serum levels of both HA and MMP-3, whereas ibuprofen increased moderately but significantly the serum concentrations of MMP-3 and had no effect on the serum concentrations of HA. The two NSAIDs were unable to change the serum levels of both TIMP-1 and YKL-40. These results suggest that nimesulide might have a favourable effect on the metabolism of OA joints. FAU - Bevilacqua, Maurizio AU - Bevilacqua M AD - Department of Endocrinology, Hospital Luigi Sacco, 20157 Milan, Italy. FAU - Devogelaer, Jean-Pierre AU - Devogelaer JP FAU - Righini, Velella AU - Righini V FAU - Famaey, Jean-Pierre AU - Famaey JP FAU - Manicourt, Daniel-Henri AU - Manicourt DH LA - eng PT - Clinical Trial PT - Journal Article PT - Randomized Controlled Trial PL - England TA - Int J Clin Pract Suppl JT - International journal of clinical practice. Supplement JID - 9712380 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (Biomarkers) RN - 0 (Sulfonamides) RN - 9004-61-9 (Hyaluronic Acid) RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) RN - V4TKW1454M (nimesulide) SB - IM MH - Aged MH - Aged, 80 and over MH - Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use MH - Biomarkers/blood MH - Female MH - Humans MH - Hyaluronic Acid/*blood MH - Male MH - Matrix Metalloproteinase 3/*blood MH - Middle Aged MH - Osteoarthritis/blood/*drug therapy MH - Pilot Projects MH - Single-Blind Method MH - Sulfonamides/*therapeutic use EDAT- 2005/07/23 09:00 MHDA- 2005/11/08 09:00 CRDT- 2005/07/23 09:00 PHST- 2005/07/23 09:00 [pubmed] PHST- 2005/11/08 09:00 [medline] PHST- 2005/07/23 09:00 [entrez] PST - ppublish SO - Int J Clin Pract Suppl. 2004 Oct;(144):13-9.